Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pramlintide acetate injection adjunct to insulin in type 2 diabetes
CTR20150265Phase 3Active
- Sponsor
- Heze Pharma
- Start
- Apr 2015
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of pramlintide in type 2 diabetes mellitus (T2DM), sponsored by Heze Pharma. Started Apr 2015; status: active.
02
Drugs
pramlintide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20150265.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150265.